UnitedHealth's troubles extend beyond regulatory scrutiny. The company has endured a tumultuous period, with its shares plummeting more than 42% over the past year. Skyrocketing medical costs led UnitedHealth to suspend its 2025 forecast, a move that rattled investors. The unexpected departure of former CEO Andrew Witty further destabilized the company, while a historic cyberattack in 2024 exposed vulnerabilities in its operations. The murder of UnitedHealthcare's CEO Brian Thompson triggered a wave of public backlash, compounding the company's reputational challenges.